Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells

Microbiology and Immunology

Volumn 45, Issue 12, 2001, Pages 829-840

  Noguchi, Tohru ^a   Satoh, Shinya ^b   Noshi, Takeshi ^b   Hatada, Eriko ^c   Fukuda, Ryuji ^c   Kawai, Akihiko ^b   Ikeda, Satoru ^a   Hijikata, Makoto ^b   Shimotohno, Kunitada ^b  

^a JAPAN TOBACCO INC   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Interferon (IFN); NS5A; PKR

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; NONSTRUCTURAL PROTEIN 5A; PROTEIN KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; GENE MUTATION; GENE REPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAMMAL CELL; MUTANT; OSTEOSARCOMA CELL; PROTEIN PROTEIN INTERACTION; VESICULAR STOMATITIS VIRUS; VIRUS RESISTANCE;

HEPATITIS C VIRUS; MAMMALIA; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0035661068     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb01322.x     Document Type: Article

References (40)

1. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A dependent phosphorylation
2. The MxA protein levels in whole blood lysates of patients with various viral infections
3. Genetic organization and diversity of the hepatitis C virus
4. Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus
5. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
6. Mutations in the nonstructural protein 5A gene and response to interferon I patients with chronic hepatitis C virus 1b infection
7. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis
8. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by nonstructural 5A protein
9. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase
10. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanism of kinase regulation
11. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells
12. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
13. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus
14. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus
15. Hepatitis C viruses
16. Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-α catalytic subunit
17. Production of two phosphoproteins from the NS5A region of the hepatitis C virus genome
18. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hapatitis
19. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes
20. Hepatitis C virus NS5A protein is phosphorylated by casein kinase II
21. Therapy of hepatitis C: Overview
22. Lack of clinical evidence for involvement of hepatitis C virus interferon-sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses
23. Prospective characterization of full-length hapatitis C virus NS5A quasispecies during induction and combination antiviral therapy
24. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes
25. Nucleotide sequence of the genomic of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions
26. Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response
27. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
28. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication
29. The NS5A/NS5 proteins of viruses from three genera of the family Flaviviridae are phosphorylated by associated serine/threonine kinases
30. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: Properties of the NS5A-associated kinase
31. Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response
32. Interferon-induced antiviral action and their regulation
33. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon
34. Long-term response to interferon alpha is unrelated "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection
35. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus
36. Structure and organization of the hepatitis C virus genome isolated from human carriers
37. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A
38. HCV-associated liver cancer
39. Interferons and other cytokines
40. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways